HCPLive Network

Hearing Loss Linked to Cognitive Impairment in Elderly Patients

 
MONDAY, Jan. 21 (HealthDay News) -- For older adults, hearing loss is independently associated with incident cognitive impairment; and about 11 percent of those aged 80 or older have dual sensory impairment (DSI), according to two studies published online Jan. 21 in JAMA Internal Medicine.

Frank R. Lin, M.D., Ph.D., from the Johns Hopkins School of Medicine in Baltimore, and colleagues examined whether hearing loss is independently correlated with accelerated cognitive decline among 1,984 older adults without prevalent cognitive impairment at baseline. The researchers found that, compared to those with normal hearing, among the 1,162 individuals with baseline hearing loss, the annual rates of cognitive decline were 41 percent greater on the Modified Mini-Mental State Examination score and 32 percent greater on the Digit Symbol Substitution test scores. Compared to those with normal hearing, individuals with hearing loss at baseline had a significantly increased risk (24 percent greater) for incident cognitive impairment.

Bonnielin K. Swenor, M.P.H., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues examined the prevalence of DSI in hearing and vision using data from the 1999 to 2006 cycles of the National Health and Nutritional Examination Survey. The researchers found that approximately 1.5 million Americans aged 20 years and older had DSI. The prevalence of DSI was less than 1 percent for individuals younger than 70 years and was 11.3 percent for those aged 80 or older. Only 19 percent of those aged 80 or older were free of any sensory impairment.

"Concurrent vision impairment could potentially accelerate the rate of cognitive decline and dementia previously reported in individuals with hearing impairment alone," Swenor and colleagues conclude.

An author associated with both studies disclosed financial ties to Pfizer and Cochlear Europe.
 

Abstract - Lin
Full Text (subscription or payment may be required)
 
Abstract - Swenor
Full Text (subscription or payment may be required)
 
Editorial (subscription or payment may be required)


Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Study results show that patients diagnosed with fibromyalgia often discontinue treatment. Those that do not frequently augment their initial treatment regimen with one or more additional medications, including some that are not recommended by current guidelines.
The patient-reported painDETECT questionnaire has been shown to accurately and reliably identify neuropathic pain across a range of conditions.
Knowledge of dietary supplement properties, uses, and contraindications is highly relevant to any health care practitioner that treats patients with chronic pain. Data shows that the top four reasons for supplement use are back pain, neck pain, joint pain, and arthritis.
Research indicates that there are probable etiologies of low back pain that can affect treatment outcome and that ignoring pain can possibly cause chronic neurological changes.
Researchers are learning more about the ways in which gut microbiota interact with the central nervous system and the role this can play in pain management.
Although the underlying mechanisms are not fully understood, opioid-induced hyperalgesia occurs in some patients on higher doses of opioids. Treatment options include reducing, rotating, or completely tapering the opioid regimen.
Magnetic resonance is an effective alternative to biopsy for identifying and quantifying fats in the liver, according to results from a study led by a research team at the University of the Basque Country.
More Reading